652 related articles for article (PubMed ID: 30222515)
1. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K
Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576
[TBL] [Abstract][Full Text] [Related]
3. The influence of Epstein-Barr virus reactivation in patients with Graves' disease.
Nagata K; Fukata S; Kanai K; Satoh Y; Segawa T; Kuwamoto S; Sugihara H; Kato M; Murakami I; Hayashi K; Sairenji T
Viral Immunol; 2011 Apr; 24(2):143-9. PubMed ID: 21449724
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface.
Nagata K; Nakayama Y; Higaki K; Ochi M; Kanai K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Iwasaki T; Nanba E; Kimura H; Hayashi K
Autoimmunity; 2015; 48(5):328-35. PubMed ID: 25759125
[TBL] [Abstract][Full Text] [Related]
5. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls.
Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies.
Tamoto N; Nagata K; Hara S; Nakayama Y; Kuwamoto S; Matsushita M; Kato M; Hayashi K
Viral Immunol; 2019 Nov; 32(9):362-369. PubMed ID: 31580214
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T
Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137
[TBL] [Abstract][Full Text] [Related]
8. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals.
Nagata K; Higaki K; Nakayama Y; Miyauchi H; Kiritani Y; Kanai K; Matsushita M; Iwasaki T; Sugihara H; Kuwamoto S; Kato M; Murakami I; Nanba E; Kimura H; Hayashi K
Autoimmunity; 2014 May; 47(3):193-200. PubMed ID: 24467196
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus in the enlarged salivary tissues of patients with IgG4-related disease.
Furukawa T; Shimotai Y; Ohta N; Ishida A; Kurakami K; Suzuki H; Yamakawa M; Hongo S; Kakehata S
Laryngoscope; 2015 Sep; 125(9):2079-84. PubMed ID: 26152762
[TBL] [Abstract][Full Text] [Related]
10. No definite clinical features of immunoglobulin G4-related disease in patients with pulmonary nodular lymphoid hyperplasia.
Bois MC; Sekiguchi H; Ryu JH; Yi ES
Hum Pathol; 2017 Jan; 59():80-86. PubMed ID: 27720730
[TBL] [Abstract][Full Text] [Related]
11. Graves' Disease Patients with Persistent Hyperthyroidism and Diffuse Lymphoplasmacytic Infiltration in the Thyroid Show No Histopathological Compatibility with IgG4-Related Disease.
Nishihara E; Hirokawa M; Ito M; Fukata S; Nakamura H; Amino N; Miyauchi A
PLoS One; 2015; 10(7):e0134143. PubMed ID: 26218874
[TBL] [Abstract][Full Text] [Related]
12. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
Yokoyama N; Izumi M; Katamine S; Nagataki S
J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.
Kumata K; Nagata K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Fukata S; Hayashi K
Viral Immunol; 2016 Oct; 29(8):459-463. PubMed ID: 27529807
[TBL] [Abstract][Full Text] [Related]
18. The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases.
Janegova A; Janega P; Rychly B; Kuracinova K; Babal P
Endokrynol Pol; 2015; 66(2):132-6. PubMed ID: 25931043
[TBL] [Abstract][Full Text] [Related]
19. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
20. Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.
Leo M; Maggi F; Dottore GR; Casini G; Mazzetti P; Pistello M; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 May; 40(5):499-503. PubMed ID: 27987077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
